{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T04:12:31Z","timestamp":1770005551926,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009836","name":"HSC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005725","name":"CHDI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.neuroscience.2017.03.051","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T02:22:02Z","timestamp":1491445322000},"page":"79-87","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["p35 hemizygosity activates Akt but does not improve motor function in the YAC128 mouse model of Huntington\u2019s disease"],"prefix":"10.1016","volume":"352","author":[{"given":"Kevin H.J.","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Franciosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Parrant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ge","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blair R.","family":"Leavitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2017.03.051_b0005","doi-asserted-by":"crossref","first-page":"7318","DOI":"10.1523\/JNEUROSCI.1831-07.2007","article-title":"Phopshorylation of huntingtin by cyclin-dependent kinase 5 is induced by DNA damage and regulates wild-type and mutant huntingtin toxicity in neurons","volume":"27","author":"Anne","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0010","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1093\/hmg\/ddn159","article-title":"Sex differences in a transgenic rat model of Huntington\u2019s disease : decreased 17\u03b2-estradiol levels correlate with reduced numbers of DARPP32 1 neurons in males","volume":"17","author":"Bode","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0015","doi-asserted-by":"crossref","first-page":"33791","DOI":"10.1074\/jbc.M204861200","article-title":"Glycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington\u2019s disease mutation","volume":"277","author":"Carmichael","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0896-6273(01)80044-1","article-title":"Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality","volume":"18","author":"Chae","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0025","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1046\/j.1471-4159.1999.0721890.x","article-title":"Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin","volume":"72","author":"Chen","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0030","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.tcb.2011.11.003","article-title":"Cdk5: a multifaceted kinase in neurodegenerative diseases","volume":"22","author":"Cheung","year":"2012","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0035","doi-asserted-by":"crossref","first-page":"15237","DOI":"10.1074\/jbc.C200032200","article-title":"Identification of a neuronal Cdk5 activator-binding protein as Cdk5 inhibitor","volume":"277","author":"Ching","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0040","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0378-1119(99)00499-0","article-title":"Cloning of three novel neuronal Cdk5 activator binding proteins","volume":"242","author":"Ching","year":"2000","journal-title":"Gene"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0045","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1038\/sj.cdd.4401967","article-title":"Increased apoptosis, Huntingtin inclusions and altered differentiation in muscle cell cultures from Huntington\u2019s disease subjects","volume":"13","author":"Ciammola","year":"2006","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0050","doi-asserted-by":"crossref","first-page":"12725","DOI":"10.1523\/JNEUROSCI.4619-08.2008","article-title":"Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity","volume":"28","author":"Cowan","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2017.03.051_b9000","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/378785a0","article-title":"Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B","volume":"378","author":"Cross","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0055","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pneurobio.2006.11.003","article-title":"N-methy-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington\u2019s disease","volume":"81","author":"Fan","year":"2007","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0060","doi-asserted-by":"crossref","first-page":"13614","DOI":"10.1523\/JNEUROSCI.3455-07.2007","article-title":"Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington\u2019s disease","volume":"27","author":"Fernandes","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/jnnp.66.1.52","article-title":"Differences in duration of Huntington\u2019s disease based on age at onset","volume":"66","author":"Foroud","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0070","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","article-title":"Identification of Genetic Factors that Modify Clinical Onset of Huntington\u2019s Disease","volume":"162","author":"Gem","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0075","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.3155875","article-title":"Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington\u2019s disease","volume":"227","author":"Graveland","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0080","doi-asserted-by":"crossref","first-page":"10633","DOI":"10.1523\/JNEUROSCI.23-33-10633.2003","article-title":"Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice","volume":"23","author":"Hallows","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0085","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"HDCRG","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0090","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0304-3940(91)90583-F","article-title":"Neuronal loss in layers V and VI of cerebral cortex in Huntington\u2019s disease","volume":"133","author":"Hedreen","year":"1991","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0095","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1471-4159.2010.07050.x","article-title":"Regulation and role of cyclin-dependent kinase activity in neuronal survival and death","volume":"115","author":"Hisanaga","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0100","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1534-5807(02)00188-0","article-title":"The IGF-1\/Akt pathway is neuroprotective in Huntington\u2019s disease and involves Huntingtin phosphorylation by Akt","volume":"2","author":"Humbert","year":"2002","journal-title":"Dev Cell"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cell.2006.08.033","article-title":"SIN1\/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity","volume":"127","author":"Jacinto","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0110","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/mds.21550","article-title":"Myopathy as a first symptom of Huntington\u2019s disease in a Marathon runner","volume":"22","author":"Kosinski","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0115","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1172\/JCI80339","article-title":"Serine 421 regulates mutant huntingtin toxicity and clearance in mice","volume":"126","author":"Kratter","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0120","doi-asserted-by":"crossref","first-page":"17166","DOI":"10.1074\/jbc.M907757199","article-title":"Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25","volume":"275","author":"Kusakawa","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0125","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/(SICI)1096-9861(19980615)395:4<510::AID-CNE7>3.0.CO;2-4","article-title":"A novel disruption of cortical development in p35(\u2212\/\u2212) mice distinct from reeler","volume":"395","author":"Kwon","year":"1998","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0130","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/(SICI)1096-9861(19991213)415:2<218::AID-CNE6>3.0.CO;2-F","article-title":"Callosal axon guidance defects in p35(\u2212\/\u2212) mice","volume":"415","author":"Kwon","year":"1999","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0135","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1074\/jbc.271.3.1538","article-title":"Interaction of cyclin-dependent kinase 5 (Cdk5) and neuronal Cdk5 activator in bovine brain","volume":"271","author":"Lee","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0140","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/35012636","article-title":"Neurotoxicity induces cleavage of p35 to p25 by calpain","volume":"405","author":"Lee","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0145","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pneurobio.2011.03.006","article-title":"Cdk5: multitasking between physiological and pathological conditions","volume":"94","author":"Lopes","year":"2011","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0150","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1083\/jcb.200412071","article-title":"Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: implication for mutant huntingtin toxicity","volume":"169","author":"Luo","year":"2005","journal-title":"J Cell Biol"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0155","doi-asserted-by":"crossref","first-page":"14671","DOI":"10.1074\/jbc.M109.066118","article-title":"P35 is required for CDK5 activation in cellular senescence","volume":"285","author":"Mao","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0160","doi-asserted-by":"crossref","first-page":"14318","DOI":"10.1523\/JNEUROSCI.1589-10.2010","article-title":"Phosphorylation of huntingtin at Ser421 in YAC128 neurons is associated with protection of YAC128 neurons from NMDA-mediated excitotoxicity and is modulated by PP1 and PP2A","volume":"30","author":"Metzler","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0165","doi-asserted-by":"crossref","first-page":"10090","DOI":"10.1523\/JNEUROSCI.3237-08.2008","article-title":"Dopaminergic and glutamatergic signaling crosstalk in Huntington\u2019s disease neurodegeneration: the role of p25\/cyclin-dependent kinase 5","volume":"28","author":"Paoletti","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JHD-2012-129000","article-title":"Decreasing levels of the cdk5 activators, p25 and p35, reduces excitotoxicity in striatal neurons","volume":"1","author":"Park","year":"2012","journal-title":"J Huntington\u2019s Dis"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0175","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/45159","article-title":"Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration","volume":"402","author":"Patrick","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0180","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1093\/nar\/gks240","article-title":"The CDK5 repressor CDK5RAP1 is a methylthiotransferase acting on nuclear and mitochondrial RNA","volume":"40","author":"Reiter","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0185","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1523\/JNEUROSCI.14-06-03934.1994","article-title":"Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain","volume":"14","author":"Roberts-Lewis","year":"1994","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0190","doi-asserted-by":"crossref","unstructured":"Roos RA, Vegter-van der Vlis M, Hermans J, Elshove HM, Moll AC, van de Kamp JJ, Bruyn GW (1991) Age at onset in Huntington\u2019s disease: effect of line of inheritance and patient\u2019s sex. J Med Genet 28:515\u2013519.","DOI":"10.1136\/jmg.28.8.515"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0195","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0200","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/cne.10938","article-title":"Evidence for progression in frontal cortical pathology in late-stage Huntington\u2019s disease","volume":"468","author":"Selemon","year":"2004","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0205","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1152\/ajpendo.00630.2010","article-title":"Molecular characterization of skeletal muscle atrophy in the R6 \/ 2 mouse model of Huntington \u2019 s disease","volume":"301","author":"She","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0210","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0215","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/A:1006857527588","article-title":"Potential mechanism(s) involved in the regulation of glycogen synthesis by insulin","volume":"182","author":"Srivastava","year":"1998","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0220","doi-asserted-by":"crossref","first-page":"26897","DOI":"10.1074\/jbc.270.45.26897","article-title":"An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator","volume":"270","author":"Tang","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0225","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/371419a0","article-title":"P35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5","volume":"371","author":"Tsai","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0230","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","article-title":"Beyond the brain: widespread pathology in Huntington\u2019s disease","volume":"8","author":"van der Burg","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2017.03.051_b9010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.nbd.2006.12.010","article-title":"Phenotypic abnormalities in the YAC128 mouse model of Huntington disease are penetrant on multiple genetic backgrounds and modulated by strain","volume":"26","author":"Van Raamsdonk","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0235","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/hmg\/ddi165","article-title":"Huntingtin phosphorylation on serine 421 is significantly reduced in the striatum and by polyglutamine expansion in vivo","volume":"14","author":"Warby","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0240","first-page":"121","article-title":"Phosphorylation of huntingtin reduces the accumulation of its nuclear fragments","volume":"40","author":"Warby","year":"2009","journal-title":"MCN"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0245","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cmet.2015.01.019","article-title":"Cdk5rap1-mediated 2-methylthio modification of mitochondrial tRNAs governs protein translation and contributes to myopathy in mice and humans","volume":"21","author":"Wei","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0250","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0962-8924(96)10023-4","article-title":"GSK3: a SHAGGY frog story","volume":"6","author":"Welsh","year":"1996","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.neuroscience.2017.03.051_b0255","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-d-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington\u2019s disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452217302269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452217302269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T02:03:27Z","timestamp":1601863407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452217302269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":53,"alternative-id":["S0306452217302269"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2017.03.051","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}